Investor Relations

News Releases

Date Title and Summary Additional Formats
Toggle Summary Anika to Issue Fourth-Quarter and Full-Year 2018 Financial Results and Business Highlights on Thursday, February 21
BEDFORD, Mass. --(BUSINESS WIRE)--Feb. 7, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its fourth-quarter and full-year 2018 financial results after the close of the market on Thursday, February 21, 2019 and hold its investor conference call on the
View HTML
Toggle Summary Anika Announces Plans to Showcase HYALOFAST at the International Cartilage Regeneration and Joint Preservation Society (ICRS) Summit in San Diego
BEDFORD, Mass. --(BUSINESS WIRE)--Jan. 16, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology , today announced plans to showcase HYALOFAST , a
View HTML
Toggle Summary Anika to Showcase HYALOFAST at the International Cartilage Regeneration and Joint Preservation Society (ICRS) Focus Meeting in Milan
BEDFORD, Mass. --(BUSINESS WIRE)--Dec. 12, 2018-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology , today announced plans to showcase its entire
View HTML
Toggle Summary Anika Resumes Global Distribution of HYALOFAST, HYALOGRAFT-C and HYALOMATRIX
Company Expands HYALOFAST Commercial Reach in Asia , the Middle East and Latin America BEDFORD, Mass. --(BUSINESS WIRE)--Dec. 4, 2018-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary
View HTML
Toggle Summary Anika Reports Third Quarter 2018 Financial Results
CINGAL Drives Strong International Viscosupplement Revenue Growth Achieves Solid Bottom Line Performance with $0.53 Diluted EPS BEDFORD, Mass. --(BUSINESS WIRE)--Oct. 24, 2018-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing
View HTML
Toggle Summary Susan Vogt Appointed to Board of Directors of Anika Therapeutics
Long-Serving Director Steven Wheeler to Retire from Board in February 2019 BEDFORD, Mass. --(BUSINESS WIRE)--Oct. 24, 2018-- Anika Therapeutics, Inc. (NASDAQ: ANIK) (“Anika” or the “Company”), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on
View HTML
Toggle Summary Anika to Issue Third-Quarter 2018 Financial Results and Business Highlights on Wednesday, October 24
BEDFORD, Mass. --(BUSINESS WIRE)--Oct. 10, 2018-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its third-quarter 2018 financial results after the close of the market on Wednesday, October 24, 2018 and hold its investor conference call on the same day,
View HTML
Toggle Summary Anika Appoints Dr. Cheryl Blanchard to Its Board of Directors
BEDFORD, Mass. --(BUSINESS WIRE)--Sep. 5, 2018-- Anika Therapeutics, Inc. (NASDAQ: ANIK) (“Anika” or the “Company”), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology , today announced that
View HTML
Toggle Summary Anika to Participate in the 2018 Morgan Stanley Global Healthcare Conference on September 12, 2018
BEDFORD, Mass. --(BUSINESS WIRE)--Sep. 5, 2018-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology , today announced that its President and Chief
View HTML
Toggle Summary Anika Reports Second Quarter 2018 Financial Results
Solid Top and Bottom Line Performance with 8% Product Revenue Growth and $0.68 Diluted EPS New Leadership Added to Optimize Commercial Reach and Operating Efficiency Multiple Initiatives Ongoing to Gain U.S. Regulatory Approval of CINGAL BEDFORD, Mass. --(BUSINESS WIRE)--Jul.
View HTML